Fact-checked by the Peptide Authority Editorial Board · Last reviewed: 2026-03-08
What Is NAD+? Benefits, Research & Safety
An essential coenzyme involved in cellular energy production and DNA repair, central to ageing research and available as IV infusions and oral precursor supplements.
Also known as:
Nicotinamide Adenine Dinucleotide
NAD
Coenzyme I
DPN
Educational Content Only: This page provides research-based information for educational purposes. NAD+ is not an approved medicine. This is not medical advice. Always consult a qualified healthcare professional.
Quick Facts
Category
Longevity & Anti-Ageing
Half-Life
NAD+ itself has a half-life of hours in circulation; tissue NAD+ pools are maintained by continuous synthesis
UK Status
NAD+ precursors (NMN, NR) are available as food supplements. IV NAD+ available at private clinics (not NHS-funded).
EU Status
NR is available as a supplement. NMN regulatory status varies by country—classified as Novel Food in some jurisdictions.
Overview
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, essential for fundamental biological processes including energy metabolism, DNA repair, gene expression regulation, and cellular signaling. While technically a dinucleotide rather than a peptide, NAD+ is extensively discussed alongside peptide therapies in longevity and anti-ageing contexts.
NAD+ levels decline significantly with age—studies suggest a 50% reduction between ages 40 and 60. This decline is associated with mitochondrial dysfunction, accumulation of DNA damage, chronic inflammation ("inflammaging"), and many age-related diseases.
The NAD+ longevity field was revolutionised by the work of David Sinclair and Leonard Guarente, who showed that NAD+-dependent enzymes called sirtuins (particularly SIRT1-7) regulate ageing pathways. Sirtuins require NAD+ as a cofactor, linking NAD+ depletion directly to accelerated ageing.
NAD+ can be replenished through several approaches:
- **IV NAD+ infusions:** Direct intravenous administration (expensive, time-consuming)
- **Precursor supplementation:** NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are orally available precursors
- **Lifestyle:** Exercise, caloric restriction, and circadian rhythm optimisation support NAD+ levels
NAD+ IV therapy has become popular in longevity clinics worldwide. Oral precursors (particularly NMN) are widely available as supplements. While preclinical evidence is compelling, large-scale human clinical trials are still limited.
Discovery & History
NAD+ was discovered in 1906 by Arthur Harden and William Young as a factor enhancing the rate of fermentation in yeast extracts. Hans von Euler-Chelpin determined its structure and shared the 1929 Nobel Prize with Harden for this work.
The role of NAD+ in cellular metabolism was established through mid-20th century biochemistry, with its function in redox reactions (NAD+/NADH) becoming a cornerstone of metabolic understanding.
The modern NAD+ renaissance began in the 2000s with two key discoveries:
- Leonard Guarente's work showing that sirtuins (NAD+-dependent deacetylases) regulate ageing in yeast, worms, and flies
- David Sinclair's research demonstrating that boosting NAD+ levels with precursors like NMN could reverse aspects of ageing in mice
The 2013 landmark paper by Gomes et al. showed that declining NAD+ levels drove age-related mitochondrial dysfunction and that NMN supplementation could reverse this. This sparked enormous research interest and commercial development.
Clinical trials of NAD+ precursors in humans began around 2017, with NR (Niagen) and NMN studies showing safety and ability to raise NAD+ levels. The human evidence base continues to grow rapidly.
Mechanism of Action
NAD+ is involved in hundreds of enzymatic reactions:
**Sirtuin Activation**
NAD+-dependent deacetylases crucial for longevity:
- SIRT1: Metabolic regulation, DNA repair, inflammation control
- SIRT3: Mitochondrial function and antioxidant defence
- SIRT6: Genomic stability and telomere maintenance
- All sirtuins require NAD+ as an essential cofactor
- NAD+ decline reduces sirtuin activity, accelerating ageing
**Cellular Energy Production**
Central role in metabolism:
- NAD+/NADH redox pair essential for glycolysis
- Critical for mitochondrial electron transport chain
- Required for fatty acid oxidation
- Supports cellular ATP production
**DNA Repair**
Via PARP enzymes:
- PARP1 and PARP2 use NAD+ for DNA strand break repair
- Chronic DNA damage increases PARP activity
- Excessive PARP activation depletes NAD+ pools
- Creates a vicious cycle of damage and depletion with ageing
**CD38 and NAD+ Consumption**
Age-related NAD+ decline mechanism:
- CD38 (a NADase) increases with age and inflammation
- CD38 is a major consumer of NAD+ in ageing tissues
- Inhibiting CD38 may help preserve NAD+ levels
- Represents a therapeutic target for NAD+ restoration
[Molecular Structure Diagram Placeholder]
Researched Benefits
Based on preclinical and clinical research findings:
- 1Restored mitochondrial function in aged mice (preclinical)
- 2Improved insulin sensitivity and metabolic parameters (animal studies)
- 3Enhanced DNA repair capacity (preclinical)
- 4Cardiovascular protection in animal models
- 5Neuroprotection and cognitive improvement (animal studies)
- 6Safe elevation of blood NAD+ levels in humans (clinical trials of NMN/NR)
- 7Potential exercise performance enhancement (limited human data)
Theoretical Dosing & Protocols
⚠️ Educational Only: The following information is derived from research literature and is not a prescription or recommendation. No standardised human dosing exists. Always consult a qualified healthcare professional.
| Theoretical Dosage | IV NAD+: 250-750mg per infusion. Oral NMN: 250-1000mg daily. Oral NR: 300-1000mg daily. |
| Frequency | IV: weekly to monthly sessions. Oral precursors: daily supplementation. |
| Duration | Ongoing; NAD+ levels decline without continued supplementation |
| Notes | NAD+ IV infusions are available at longevity clinics (expensive, £200-500+ per session). Oral precursors (NMN, NR) are available as food supplements without prescription. Quality varies significantly between products. Long-term human efficacy data for anti-ageing is still limited. |
Administration Routes
Routes studied in research settings (educational only):
- Intravenous infusion (IV NAD+)
- Oral (NMN and NR precursor supplements)
- Sublingual (some NMN formulations)
- Intranasal (experimental)
| Half-Life | Stability |
|---|---|
| NAD+ itself has a half-life of hours in circulation; tissue NAD+ pools are maintained by continuous synthesis | IV NAD+ solutions prepared fresh; NMN/NR supplements stable as dry powder |
Safety Profile & Known Risks
Commonly Reported Side Effects
- IV NAD+: nausea, cramping, chest tightness during infusion
- Flushing and warmth (IV)
- Headache
- Mild GI discomfort with oral precursors
- IV infusions can be uncomfortable (2-4 hour duration)
Rare Risks & Concerns
- Theoretical concern about supporting tumour metabolism
- Interaction with NAD+-dependent drug metabolism
- Limited long-term safety data for high-dose supplementation
- IV complications (standard IV risks)
Contraindications
- Active cancer (theoretical concern about fuelling tumour metabolism)
- Pregnancy and breastfeeding (insufficient safety data)
- Concurrent use of NAD+-affecting medications
UK & EU Regulatory Context
🇬🇧 United Kingdom
NAD+ precursors (NMN, NR) are available as food supplements. IV NAD+ available at private clinics (not NHS-funded).
🇪🇺 European Union
NR is available as a supplement. NMN regulatory status varies by country—classified as Novel Food in some jurisdictions.
NAD+ and its precursors are not classified as medicines. IV NAD+ therapy is available privately but not evidence-based by NHS standards. NMN was briefly under FDA scrutiny in the US but remains available as a supplement. The field is rapidly evolving with ongoing clinical trials.
Clinical Studies Summary
NMN Supplementation in Humans
Clinical trials showing oral NMN safely elevates blood NAD+ levels in healthy adults, with some evidence for improved insulin sensitivity and muscle function.
Science. 2022; Various clinical trial publicationsView on PubMed
NR (Niagen) Human Safety and Efficacy
Multiple trials demonstrating NR supplementation safely increases NAD+ metabolites in humans, with studies in ageing, metabolic health, and cardiovascular function.
Nature Communications. 2018View on PubMed
Looking for NAD+?
Source research-grade NAD+ from a trusted UK supplier — third-party tested with certificate of analysis.
View at SupplierFrequently Asked Questions
Related Research Guides
Related Peptides
Epitalon
A synthetic tetrapeptide based on epithalamin, researched for its potential effects on telomerase activation and biological ageing.
Learn moreMOTS-c
A mitochondrial-derived peptide that regulates metabolic homeostasis and exercise adaptations, representing a novel class of signalling molecules.
Learn moreHumanin
A mitochondrial-derived peptide with cytoprotective and anti-apoptotic properties, researched for neuroprotection, metabolic regulation, and ageing.
Learn moreSS-31
A mitochondria-targeted tetrapeptide in clinical trials for heart failure, mitochondrial myopathy, and age-related mitochondrial dysfunction.
Learn more